Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the period of June 2021. The report serves to notify shareholders of the postponement of the Annual General Meeting originally scheduled for May 31, 2021, to June 7, 2021, at 3:00 p.m. Israel time.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the rescheduling of the Annual General Meeting. No financial or operational changes compared to prior periods are disclosed in this text.
Guidance, Outlook, and Risks
Management commentary is limited to the logistical details of the reconvened meeting. The filing includes attached exhibits for the Notice and Proxy Statement, Proxy Card, and Voting Instruction Card. No specific guidance, outlook, risks, or contingencies are detailed in the body of this report.
Key Facts for Investors
- The Annual General Meeting was postponed from May 31, 2021, to June 7, 2021.
- The meeting location is the Company's offices at 10 Bareket Street, Petach Tikva, Israel.
- Shareholders may vote in person or by proxy using the forms provided in the exhibits.
- This filing incorporates by reference into the Company's Registration Statements on Form S-8 and Form F-3.